Moderna
-
Finance
Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector
Oct 1 (Reuters) – Optimistic scientific trial outcomes for Merck & Co’s experimental antiviral COVID-19 capsule reverberated by the healthcare…
Read More » -
Finance
Analysis: Torrid Moderna stock rally cools over booster shot doubts
NEW YORK, Sept 17 (Reuters) – Debate over the necessity for COVID-19 booster pictures is clouding the outlook for Moderna…
Read More »